HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Antiperspirants and cancer

This article was originally published in The Rose Sheet

Executive Summary

Use of antiperspirants or deodorants was not linked to an increased risk of breast cancer in a population-based case-control study published in the Oct. 16 Journal of the National Cancer Institute. Conducted by Dana Mirick, Fred Hutchinson Cancer Research Center, Seattle, et al., study involved 810 women diagnosed with breast cancer, 793 controls who were interviewed about antiperspirant and deodorant use following underarm hair removal. "To our knowledge," researchers state, "this is the only epidemiologic evidence pertaining to a possible association" between antiperspirants/deodorants and breast cancer and "our results provide no indication that such a relationship exists." Study prompted by "persistent" Internet rumors of a connection between the products and cancer...

You may also be interested in...


Dove and Axe marketer unveils consumer Web site this month on antiperspirant safety in response to reports linking the products to breast cancer, firm says. Site, which can be accessed at 1www.antiperspirantsinfo.com or 2www.deodorantinfo.com, features expert opinions from physicians, frequently asked questions and links to further information. Internet rumors in 2002 raised concerns over antiperspirant safety, but a study published in the Journal of the National Cancer Institute the same year demonstrated no link between antiperspirants and cancer (3"The Rose Sheet" Oct. 21, 2002, In Brief)...

Methylparaben Accumulation Noted In UK Breast Tumor Study

Additional research, including studies measuring the levels of parabens in healthy breast tissue, is needed to evaluate the possible connection between the cosmetics preservatives and breast cancer, according to a British study published in the January issue of the Journal of Applied Toxicology

Sanofi Tries To Stop Lantus Biosimilar By Getting Supreme Court To Review PTAB, Again

Sanofi seeks to delay decision clearing path for Mylan's Lantus biosimilar; says it should be able to get rehearing based on Federal Circuit's ruling that PTAB judges were not constitutionally appointed.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts